Any feedback?
Literature summary for 2.7.11.13 extracted from
- The specificities of protein kinase inhibitors: an update (2003), Biochem. J., 371, 199-204.
Activating Compound
| Activating Compound | Comment | Organism | Structure |
|---|---|---|---|
| kenpaullone | 20% activation of PKCalpha at 0.01 mM | Homo sapiens |  |
Inhibitors
| Inhibitors | Comment | Organism | Structure |
|---|---|---|---|
| alsterpaullone | 7% inhibition of PKCalpha at 0.01 mM | Homo sapiens | |
| indirubin-3'-monoxime | 32% inhibition of PKCalpha at 0.01 mM | Homo sapiens | |
| additional information | no inhibition of PKCalpha by roscovitine, and purvalanol | Homo sapiens |
Organism
| Organism | UniProt | Comment | Textmining |
|---|---|---|---|
| Homo sapiens | - |
- |
- |
Synonyms
| Synonyms | Comment | Organism |
|---|---|---|
| PKCalpha | - |
Homo sapiens |
Temperature Optimum [°C]
| Temperature Optimum [°C] | Temperature Optimum Maximum [°C] | Comment | Organism |
|---|---|---|---|
| 21 | - |
assay at room temperature | Homo sapiens |
pH Optimum
| pH Optimum Minimum | pH Optimum Maximum | Comment | Organism |
|---|---|---|---|
| 7.5 | - |
assay at | Homo sapiens |
Cofactor
| Cofactor | Comment | Organism | Structure |
|---|---|---|---|
| ATP | - |
Homo sapiens | |
Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.
Release 2023.1 (January 2023)
Legal
Curated at
Member of
